MUNI and Artios to get USD 30m for development of cancer drugs

Published: 09.12.2020 Related countries:  United Kingdom United Kingdom

The Masaryk University in Brno (MUNI) and Artios Pharma will get a preliminary investment of USD 30m from Merck for the development of new ways of treatment of cancer.

The sum will be received thanks to the new partnership between Merck and Artios, the goal is to develop medicaments based on the DDR priniciple (DNA Damage Response)

Source: ČIA